Germ and hematology: underlying disease influences diversity of germ spectra and antibiotic therapy.
作者信息
Schalk Enrico, Tammer Ina, Heidel Florian H
机构信息
Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
出版信息
Infect Control Hosp Epidemiol. 2014 Feb;35(2):208-10. doi: 10.1086/674864.
DOI:10.1086/674864
PMID:24442091
Abstract
摘要
相似文献
1
Germ and hematology: underlying disease influences diversity of germ spectra and antibiotic therapy.细菌学与血液学：基础疾病影响细菌谱多样性及抗生素治疗。
Infect Control Hosp Epidemiol. 2014 Feb;35(2):208-10. doi: 10.1086/674864.
2
Management of bacterial infections in haematological patients.血液学患者细菌感染的管理
Br J Hosp Med. 1982 Jul;28(1):74, 76, 79 passim.
3
[Antibiotic therapy in the high risk patient (hematologic study)].[高危患者的抗生素治疗（血液学研究）]
G Clin Med. 1976 Mar-Apr;57(3-4):92-104.
4
[Fosfomycin in a hematology department].[血液科中的磷霉素]
Minerva Med. 1978 Dec 1;69(59):4111-4.
5
The use of synergistic combinations of antibiotics in patients with haematological diseases.血液系统疾病患者中抗生素协同组合的应用。
Clin Haematol. 1976 Jun;5(2):361-77.
6
[Drug therapy of infections in hematologic disorders ].[血液系统疾病中的感染药物治疗]
Nihon Rinsho. 1990 Oct;48(10):2304-10.
7
[Clinical effects of COG-78 on severe infections complicated with hematopoietic diseases--a comparative study on cross-over method].COG-78对造血系统疾病合并严重感染的临床疗效——交叉法对比研究
Kansenshogaku Zasshi. 1983 Nov;57(11):971-80. doi: 10.11150/kansenshogakuzasshi1970.57.971.
8
Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.评价头孢美唑和哌拉西林单用或联用妥布霉素治疗血液系统疾病患者感染的疗效。
Tokai J Exp Clin Med. 1981 Oct;6(4):415-20.
9
[Severe infections associated with hematological diseases].[与血液系统疾病相关的严重感染]
Rinsho Ketsueki. 2012 Oct;53(10):1784-92.
10
Treatment of infections during hematologic malignancies with aztreonam, a new antibiotic.用新型抗生素氨曲南治疗血液系统恶性肿瘤期间的感染
Chemioterapia. 1986 Dec;5(6):400-3.
Zotero 插件